definiens: means ( a ) any Compound which is a Glucagon / GLP-1 Dual Agonist and which tails within the scope of the cla ims of the Zealand Pharma Patents shown in Appendix 1.112 as of the Effective Date, including ZP2929 as defined by the amino acid sequence and structure given in that certain side l etter delivered by Zealand Pharma to BI in connection with the execution of this Agreement ( th e ) ; ( b ) all other Compounds claimed in the Licensed Patents shown in Appendix 1.112 as of the Effective Date ; ( c ) additional Glucagon / GLR 1 Dual Agonists i dentified during the Research Collaboration ; and ( d ) New Generation Compounds agr eed by the Parties to be included within the scope of this Agreement pursuant to Section 11 . 3, in each case excluding the Excluded Compounds